Founded by Dr Misti Ushio and headquartered in New York, Tara Biosystems is a human heart-on-a-chip company which has developed a proprietary platform to generate novel cardiac tissue models.
Through these physiologically human-relevant predictive models, the company offers a variety of solutions that can decisively evaluate the efficacy and risk of novel medicines, helping to reduce the time and cost of the drug discovery and development process.
Exit Date: 2022
Financing round - Series A
Life Science Tools
Investment’s Exit Date